Showing items 1–100
T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof
Grant US-11944644-B2
United States of America
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding…
Grant US-RE49847-E1
United States of America
T cells containing anti-CD38 and anti-CD138 chimeric antigen receptors and their uses
Grant JP-7437705-B2
Japan
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing…
Grant US-11896614-B2
United States of America
Method of treating cancer by administering immune effector cells expressing a chimeric…
Grant US-11872249-B2
United States of America
Compositions and methods for immunooncology
Grant US-11851659-B2
United States of America
A UNIVERSAL PLATFORM FOR CAR THERAPY TARGETING A NOVEL ANTIGENIC SIGNATURE OF CANCER
Application EP-4282978-A2
European Patent Office
Chimeric antigen receptors (CARs), compositions and methods thereof
Grant US-11820819-B2
United States of America
Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods of…
Grant US-11806365-B2
United States of America
Therapeutic agents
Grant US-11802143-B2
United States of America
Compositions and methods for immunotherapy
Grant US-11712469-B2
United States of America
Compositions and methods for immunotherapy
Grant AU-2020294287-B2
Australia
Chimeric antigen receptors (CARs), compositions and methods of use thereof
Grant US-11655452-B2
United States of America
Nucleic acid construct
Grant US-11613559-B2
United States of America
Chimeric antibody/T-cell receptor constructs and uses thereof
Grant US-11613573-B2
United States of America
Gene-regulating compositions and methods for improved immunotherapy
Grant US-11608500-B2
United States of America
Compositions and methods for treating mesothelin positive cancers
Grant US-11602543-B2
United States of America
Compositions and methods for treating EGFR positive cancers
Grant US-11602544-B2
United States of America
REGULATING CHIMERIC ANTIGEN RECEPTORS
Application EP-4119552-A1
European Patent Office
Tumor specific antibody conjugates and uses therefor
Grant US-11554181-B2
United States of America
Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted antigen…
Grant US-11547740-B2
United States of America
Multipartite signaling proteins and uses thereof
Grant US-11530265-B2
United States of America
Use of trans-signaling approach in chimeric antigen receptors
Grant US-11484552-B2
United States of America
Gene-regulating compositions and methods for improved immunotherapy
Grant US-11459544-B2
United States of America
Bispecific CAR T-cells for solid tumor targeting
Grant US-11458167-B2
United States of America
GPC3 and ASGPR1 double-targeted transgenic immune effector cell and use thereof
Grant US-11453860-B2
United States of America
Compositions and methods for treating ceacam positive cancers
Grant US-11433100-B2
United States of America
Gene-regulating compositions and methods for improved immunotherapy
Grant US-11421228-B2
United States of America
Transgene genetic tags and methods of use
Grant US-11414486-B2
United States of America
Systems and methods for targeting cancer cells
Grant US-11400116-B2
United States of America
Genetically modified cells and uses thereof
Grant US-11400145-B2
United States of America
Transgenic T cell and chimeric antigen receptor T cell compositions and related methods
Grant US-11377637-B2
United States of America
TWO CHIMERIC ANTIGEN RECEPTORS SPECIFICALLY BINDING CD19 AND IGKAPPA
Application US-20220177573-A1
United States of America
Gene-regulating compositions and methods for improved immunotherapy
Grant US-11332713-B2
United States of America
MODIFIED T LYMPHOCYTES HAVING IMPROVED SPECIFICITY
Application EP-3985028-A1
European Patent Office
Compositions and methods for immunotherapy
Grant US-11267901-B2
United States of America
Gene-regulating compositions and methods for improved immunotherapy
Grant US-11261428-B2
United States of America
Immune cell compositions and methods of use
Grant US-11242375-B2
United States of America
TUMOR-ACTIVATED ALLOREACTIVE AND XENOREACTIVE T CELLS AND THEIR USE IN IMMUNOTHERAPY…
Application WO-2022011065-A1
World Intellectual Property Organisation (WIPO)
Cancer antigen targets and uses thereof
Grant US-11193938-B2
United States of America
Monoclonal antibody targeting a unique sialoglycosylated cancer-associated epitope of CD43
Grant US-11174318-B2
United States of America
Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of…
Grant US-11173179-B2
United States of America
Chimeric antigen receptors
Grant US-11130820-B2
United States of America
CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR HUMAN CD45RC AND USES THEREOF
Application WO-2021186056-A1
World Intellectual Property Organisation (WIPO)
Bispecific CAR T-cells for solid tumor targeting
Grant US-11123369-B2
United States of America
T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen…
Grant US-11091532-B2
United States of America
CELL
Application EP-3858378-A1
European Patent Office
Chimeric antigen receptor (CAR) comprising a CD19-binding domain
Grant US-11034750-B2
United States of America
COMPOSITIONS AND METHODS FOR TREATING HIV/AIDS WITH IMMUNOTHERAPY
Application EP-3728307-A4
European Patent Office
Chimeric antigen receptor (CAR) comprising a CD22-binding domain
Grant US-10981970-B2
United States of America
Modified T lymphocytes comprising a BAFF antibody-inducible caspase and methods of…
Grant US-10967005-B2
United States of America
Chimeric antigen receptors (CARs), compositions and methods of use thereof
Grant AU-2016283102-B2
Australia
CELLS EXPRESSING CHIMERIC ACTIVATING RECEPTORS AND CHIMERIC STIMULATING RECEPTORS AND…
Application EP-3615046-A4
European Patent Office
IMMUNORESPONSIVE CELLS ARMOURED WITH SPATIOTEMPORALLY RESTRICTED ACTIVITY OF CYTOKINES OF…
Application WO-2021028690-A1
World Intellectual Property Organisation (WIPO)
Therapeutic agents
Grant US-10899818-B2
United States of America
Method and compositions for cellular immunotherapy
Grant US-10865242-B2
United States of America
Therapeutic agents
Grant US-10865231-B2
United States of America
Chimeric antigen receptor and its use
Grant US-10865243-B2
United States of America
Methods for improving the efficacy and expansion of immune cells
Grant US-10829735-B2
United States of America
COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
Application US-20200317781-A1
United States of America
Compositions and methods for immunotherapy
Grant AU-2018204297-B2
Australia
MUC1 PARALLEL CAR (pCAR) THERAPEUTIC AGENTS
Application WO-2020183158-A1
World Intellectual Property Organisation (WIPO)
CHIMERIC ANTIGEN RECEPTOR AND ITS USE
Grant EP-3169703-B1
European Patent Office
T-cells comprising anti-CD 38 and anti-CD 138 chimeric antigen receptors and uses thereof
Application CN-111587254-A
China
Therapeutic agents
Grant US-10703794-B2
United States of America
CHIMERIC ANTIGEN RECEPTORS (CARS), COMPOSITIONS AND METHODS THEREOF
Application EP-3474867-A4
European Patent Office
Compositions and methods for immunotherapy
Grant US-10654928-B2
United States of America
METHODS FOR IDENTIFYING ACTIVATING ANTIGEN RECEPTOR (ACAR)/INHIBITORY CHIMERIC ANTIGEN…
Application WO-2020065406-A2
World Intellectual Property Organisation (WIPO)
CELL
Application EP-3626261-A1
European Patent Office
Chimeric antigen receptor (CAR) signalling system
Grant US-10588967-B2
United States of America
MODIFIED T LYMPHOCYTES HAVING IMPROVED SPECIFICITY
Application EP-3604500-A1
European Patent Office
COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
Application EP-3597215-A1
European Patent Office
Multipartite signaling proteins and uses thereof
Grant US-10457731-B2
United States of America
Multipartite signaling proteins and uses thereof
Grant US-10428142-B2
United States of America
CELL
Grant EP-3237442-B1
European Patent Office
Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted antigen…
Grant US-10279009-B2
United States of America
A UNIVERSAL PLATFORM FOR PREPARING AN INHIBITORY CHIMERIC ANTIGEN RECEPTOR (ICAR)
Application WO-2019068007-A1
World Intellectual Property Organisation (WIPO)
CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS OF USE THEREOF
Application EP-3313872-A4
European Patent Office
Multipartite signaling proteins and uses thereof
Grant US-10196444-B2
United States of America
Cell
Grant US-10174099-B2
United States of America
Cell
Application US-10172886-B2
United States of America
Cell
Application US-10172885-B2
United States of America
METHODS AND COMPOSITIONS RELATED TO ANTIGEN PRESENTING PROTEINS
Application EP-3298035-A4
European Patent Office
Use of a trans-signaling approach in chimeric antigen receptors
Grant US-10117896-B2
United States of America
Cell
Grant US-10098926-B2
United States of America
CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF
Application US-20180162939-A1
United States of America
Nucleic acid construct
Application JP-2018514209-A
Japan
CHIMERIC RECEPTORS AND USES THEREOF IN IMMUNE THERAPY
Application WO-2017177217-A3
World Intellectual Property Organisation (WIPO)
GENETICALLY MODIFIED CELLS AND USES THEREOF
Application WO-2017088012-A1
World Intellectual Property Organisation (WIPO)
Compositions, methods, and computer systems related to making and administering modified…
Grant US-9662354-B2
United States of America
Compositions, methods, and computer systems related to making and administering modified…
Grant US-9587237-B2
United States of America
CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS OF USE THEREOF
Application WO-2016210293-A1
World Intellectual Property Organisation (WIPO)
COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS RELATED TO MAKING AND ADMINISTERING MODIFIED…
Application EP-2971288-A4
European Patent Office
NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR
Application WO-2016174406-A1
World Intellectual Property Organisation (WIPO)
NUCLEIC ACID CONSTRUCT
Application WO-2016174409-A1
World Intellectual Property Organisation (WIPO)
MODIFIED T LYMPHOCYTES HAVING IMPROVED SPECIFICITY
Application EP-2953475-A4
European Patent Office
COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
Application EP-2903637-A4
European Patent Office
CELL
Application WO-2016102965-A1
World Intellectual Property Organisation (WIPO)
CHIMERIC ANTIGEN RECEPTOR AND ITS USE
Application WO-2016008973-A1
World Intellectual Property Organisation (WIPO)
Showing items 1–100